Form 4 for IMAX IMAX CORP
Accepted 2025-01-06 00:00:00 ET · period of report 2025-01-02 · accession 0001214659-25-000204 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-01-06 | 2025-01-02 | IMAX | GELFOND RICHARD L | CEO, Dir | F - Tax | $25.11 | -97.2K | 548.6K | -15% | -$2.44M |
| DM | 2025-01-06 | 2025-01-02 | IMAX | GELFOND RICHARD L | CEO, Dir | M - OptEx | $0.00 | +175.1K | 577.0K | +44% | $0 |
| D | 2025-01-06 | 2025-01-02 | IMAX | GELFOND RICHARD L | CEO, Dir | A - Grant | $0.00 | -109.5K | 109.5K | -50% | $0 |
| DM | 2025-01-06 | 2025-01-02 | IMAX | GELFOND RICHARD L | CEO, Dir | M - OptEx | $0.00 | -175.1K | 123.4K | -59% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | common shares | 2025-01-02 | F | D | 33,840 | $25.11 | 603,500 | D | — | — | (F2) Mr. Gelfond is reporting the withholding of common shares by IMAX Corporation to satisfy the tax withholding obligation in connection with the delivery of common shares upon conversion of the restricted share unit transaction. |
| 2 | Common | common shares | 2025-01-02 | M | A | 61,192 | $0.00 | 637,340 | D | — | — | (F1) Represents the conversion of vested restricted share units into common shares. |
| 3 | Common | common shares | 2025-01-02 | F | D | 34,957 | $25.11 | 576,148 | D | — | — | (F2) Mr. Gelfond is reporting the withholding of common shares by IMAX Corporation to satisfy the tax withholding obligation in connection with the delivery of common shares upon conversion of the restricted share unit transaction. |
| 4 | Common | common shares | 2025-01-02 | M | A | 62,528 | $0.00 | 611,105 | D | — | — | (F1) Represents the conversion of vested restricted share units into common shares. |
| 5 | Common | common shares | 2025-01-02 | M | A | 51,383 | $0.00 | 576,992 | D | — | — | (F1) Represents the conversion of vested restricted share units into common shares. |
| 6 | Common | common shares | 2025-01-02 | F | D | 28,415 | $25.11 | 548,577 | D | — | — | (F2) Mr. Gelfond is reporting the withholding of common shares by IMAX Corporation to satisfy the tax withholding obligation in connection with the delivery of common shares upon conversion of the restricted share unit transaction. |
| 7 | Derivative | restricted share units | 2025-01-02 | A | D | 109,518 | $0.00 | 109,518 | D | $0.00 · — to — | 109,518 common shares | (F3) Each restricted share unit represents a contingent right to receive one common share of IMAX Corporation. (F4) Each restricted share unit is the economic equivalent of one common share of IMAX Corporation. (F6) This represents the number of restricted share units for this transaction only. Mr. Gelfond's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 1,818,695; 294,433 and 603,500 respectively. The number of outstanding options reflects the expiration of options to purchase 467,625 common shares on January 5, 2025. Mr. Gelfond did not receive any value in connection with such expiration; therefore, such expiration is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, under Rule 16b-6(d). (F7) The restricted share units vest and will be converted to common shares in three installments: 36,506 on each of January 2, 2026, January 2, 2027 and January 2, 2028. |
| 8 | Derivative | restricted share units | 2025-01-02 | M | D | 62,528 | $0.00 | 62,529 | D | $0.00 · — to — | 62,528 common shares | (F3) Each restricted share unit represents a contingent right to receive one common share of IMAX Corporation. (F1) Represents the conversion of vested restricted share units into common shares. (F4) Each restricted share unit is the economic equivalent of one common share of IMAX Corporation. (F6) This represents the number of restricted share units for this transaction only. Mr. Gelfond's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 1,818,695; 294,433 and 603,500 respectively. The number of outstanding options reflects the expiration of options to purchase 467,625 common shares on January 5, 2025. Mr. Gelfond did not receive any value in connection with such expiration; therefore, such expiration is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, under Rule 16b-6(d). (F5) The restricted share units vested and converted to common shares on January 2, 2025. |
| 9 | Derivative | restricted share units | 2025-01-02 | M | D | 51,383 | $0.00 | 0 | D | $0.00 · — to — | 51,383 common shares | (F3) Each restricted share unit represents a contingent right to receive one common share of IMAX Corporation. (F1) Represents the conversion of vested restricted share units into common shares. (F4) Each restricted share unit is the economic equivalent of one common share of IMAX Corporation. (F6) This represents the number of restricted share units for this transaction only. Mr. Gelfond's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 1,818,695; 294,433 and 603,500 respectively. The number of outstanding options reflects the expiration of options to purchase 467,625 common shares on January 5, 2025. Mr. Gelfond did not receive any value in connection with such expiration; therefore, such expiration is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, under Rule 16b-6(d). (F5) The restricted share units vested and converted to common shares on January 2, 2025. |
| 10 | Derivative | restricted share units | 2025-01-02 | M | D | 61,192 | $0.00 | 123,386 | D | $0.00 · — to — | 61,192 common shares | (F3) Each restricted share unit represents a contingent right to receive one common share of IMAX Corporation. (F4) Each restricted share unit is the economic equivalent of one common share of IMAX Corporation. (F6) This represents the number of restricted share units for this transaction only. Mr. Gelfond's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 1,818,695; 294,433 and 603,500 respectively. The number of outstanding options reflects the expiration of options to purchase 467,625 common shares on January 5, 2025. Mr. Gelfond did not receive any value in connection with such expiration; therefore, such expiration is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, under Rule 16b-6(d). (F5) The restricted share units vested and converted to common shares on January 2, 2025. |